Dr Tomas Navratil
Vice-President, Development

Is this your profile?

About

Tomas Navratil, PhD, was Vice-President, Development, at Envisia Therapeutics.

Contributions

IMPROVING OUTCOMES IN OPHTHALMOLOGY VIA SUSTAINED DRUG DELIVERY

Tomas Navratil, Benjamin Maynor and Benjamin Yerxa describe the company’s particle engineering technology and its application in improving the delivery of prostaglandin analogues and anti-VEGF therapy.

Top

W3 Total Cache is currently running in Pro version Development mode.